Rivalry Corp. (TSXV:RVLY)
0.0500
0.00 (0.00%)
Aug 1, 2025, 9:30 AM EDT
Intra-Cellular Therapies Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2020 |
Cash & Equivalents | 0.69 | 1.57 | 10.54 | 12.19 | 35.45 | 0.62 | Upgrade |
Cash & Short-Term Investments | 0.69 | 1.57 | 10.54 | 12.19 | 35.45 | 0.62 | Upgrade |
Cash Growth | -88.70% | -85.07% | -13.54% | -65.61% | 5616.37% | -82.48% | Upgrade |
Receivables | 0.11 | 0.07 | 0.01 | 0.01 | 0.29 | 5.52 | Upgrade |
Prepaid Expenses | 0.3 | 0.28 | 0.33 | 0.23 | 0.46 | 0.05 | Upgrade |
Restricted Cash | 1.17 | 1.1 | 2.93 | 4.16 | 2.14 | 0.81 | Upgrade |
Other Current Assets | 0 | - | - | - | 1.64 | - | Upgrade |
Total Current Assets | 2.26 | 3.02 | 13.8 | 16.6 | 39.99 | 7 | Upgrade |
Property, Plant & Equipment | 0.38 | 0.45 | 0.61 | 0.83 | 0.33 | 0.49 | Upgrade |
Other Intangible Assets | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | Upgrade |
Other Long-Term Assets | 0 | 0 | - | 0 | -0 | -0 | Upgrade |
Total Assets | 2.77 | 4.09 | 15.08 | 18.06 | 40.46 | 7.62 | Upgrade |
Accounts Payable | 3.49 | 3.67 | 2.92 | 2.87 | 1.33 | 0.49 | Upgrade |
Current Portion of Leases | 0.16 | 0.15 | 0.14 | 0.16 | 0.12 | 0.09 | Upgrade |
Current Unearned Revenue | 4.95 | 4.99 | - | - | - | - | Upgrade |
Other Current Liabilities | -0 | -0 | - | -0 | - | - | Upgrade |
Total Current Liabilities | 9.53 | 8.82 | 3.06 | 3.03 | 1.45 | 0.59 | Upgrade |
Long-Term Debt | 12.55 | 12.03 | 9.91 | - | - | - | Upgrade |
Long-Term Leases | - | 0.03 | 0.19 | 0.33 | 0.02 | 0.23 | Upgrade |
Other Long-Term Liabilities | - | -0 | - | - | - | - | Upgrade |
Total Liabilities | 22.08 | 20.88 | 13.15 | 3.36 | 1.47 | 0.81 | Upgrade |
Common Stock | 80.74 | 80.74 | 77.78 | 69.81 | 69.81 | 20.79 | Upgrade |
Additional Paid-In Capital | 16.33 | 15.86 | 15.14 | 16.08 | 7.74 | 0.23 | Upgrade |
Retained Earnings | -119.42 | -116.44 | -94.03 | -70.23 | -38.69 | -14.38 | Upgrade |
Comprehensive Income & Other | 3.04 | 3.04 | 3.04 | -0.96 | 0.12 | 0.17 | Upgrade |
Shareholders' Equity | -19.31 | -16.79 | 1.93 | 14.7 | 38.98 | 6.81 | Upgrade |
Total Liabilities & Equity | 2.77 | 4.09 | 15.08 | 18.06 | 40.46 | 7.62 | Upgrade |
Total Debt | 13.65 | 12.22 | 10.23 | 0.48 | 0.14 | 0.32 | Upgrade |
Net Cash (Debt) | -12.96 | -10.65 | 0.31 | 11.71 | 35.31 | 0.3 | Upgrade |
Net Cash Growth | - | - | -97.36% | -66.85% | 11689.34% | -90.44% | Upgrade |
Net Cash Per Share | -0.19 | -0.16 | 0.00 | 0.20 | 0.83 | 0.00 | Upgrade |
Filing Date Shares Outstanding | 89.49 | 89.49 | 67.25 | 62.1 | 61.03 | 62.73 | Upgrade |
Total Common Shares Outstanding | 89.49 | 89.49 | 67.08 | 62.1 | 60.76 | 62.73 | Upgrade |
Working Capital | -7.28 | -5.79 | 10.74 | 13.57 | 38.53 | 6.41 | Upgrade |
Book Value Per Share | -0.22 | -0.19 | 0.03 | 0.24 | 0.64 | 0.11 | Upgrade |
Tangible Book Value | -19.45 | -16.93 | 1.8 | 14.57 | 38.85 | 6.67 | Upgrade |
Tangible Book Value Per Share | -0.22 | -0.19 | 0.03 | 0.23 | 0.64 | 0.11 | Upgrade |
Machinery | 0.36 | 0.38 | 0.35 | 0.28 | 0.17 | 0.12 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.